Daniel de la Nava
3PUBLICATIONS
91CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Mar 30, 2024
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.Daniel de la Nava, Iker Ausejo-Mauleon, Virginia Laspidea
|Aug 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji
|Dec 30, 2021
Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory.Naiara Martinez-Velez, Virginia Laspidea, Marta Zalacain
Pageof 1
Frequent Collaborators
3 joint publications
Marta M Alonso
2 joint publications
Carl Koschmann
2 joint publications
Javad Nazarian
2 joint publications
Matthew D Dun
1 joint publications
Virginia Laspidea
1 joint publications
Marisol Gonzalez-Huarriz
1 joint publications
Guillermo Herrador
1 joint publications
Juan Fueyo
1 joint publications
Candelaria Gomez-Manzano
1 joint publications
Sriram Venneti
